Date | Price Target | Rating | Analyst |
---|---|---|---|
7/17/2024 | $43.00 → $40.00 | Underweight → Neutral | JP Morgan |
1/30/2024 | $40.00 | Neutral | Mizuho |
12/15/2023 | $38.00 | Outperform → Neutral | Robert W. Baird |
8/22/2023 | $40.00 | Neutral → Underweight | JP Morgan |
7/18/2023 | $46.00 → $42.00 | Buy → Neutral | Citigroup |
12/15/2022 | $55.00 → $50.00 | Overweight → Neutral | JP Morgan |
2/14/2022 | $57.00 → $51.00 | Outperform → Market Perform | Cowen & Co. |
1/26/2022 | $54.00 | Hold | Jefferies |
Total Revenue of $1.18 billion, Up 6% (7% constant currency)1Diluted EPS of $0.67, Up 6%; Adjusted Diluted EPS2 of $0.79, Up 10% NEW YORK, Aug. 8, 2024 /PRNewswire/ -- Genpact Limited (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced financial results for the second quarter ended June 30, 2024. "Following another quarter of better-than-expected results and a robust first half performance, we are raising our earnings expectations for the year," said Balkrishan "BK" Kalra, Genpact's President and CEO. "Our seco
NEW YORK, July 11, 2024 /PRNewswire/ -- Genpact Limited (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that its board of directors has declared a cash dividend of $0.1525 per common share for the third quarter of 2024. The dividend is payable on September 25, 2024 to shareholders of record as of the close of business on September 11, 2024. The declaration of any future dividends will be at the discretion of the board of directors. About Genpact Genpact (NYSE:G) is a global professional services and solutio
NEW YORK, July 10, 2024 /PRNewswire/ -- Genpact (NYSE:G) will announce results for the second quarter ended June 30, 2024 after the close of the U.S. financial markets on Thursday, August 8, 2024. Following the release, Genpact's management will host a conference call beginning at 5:00 p.m. ET to discuss the company's performance. Those who wish to participate can register here to receive a dial-in number and unique PIN to access the call. It is recommended callers join 10 minutes prior to the start of the event, although you may register and dial in at any time during the c
Seasoned technologist joins Genpact to accelerate AI and advanced technology roadmaps NEW YORK, Aug. 7, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Sanjeev Vohra has been named as the Company's first Chief Technology & Innovation Officer, effective immediately. Vohra will report to President and CEO, Balkrishan "BK" Kalra. Vohra, a seasoned leader and respected innovator, brings more than 30 years of technology, consulting and industry expertise to Genpact. His appointm
NEW YORK, Aug. 5, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced that Nicholas "Nick" Gangestad, Senior Vice President and Chief Financial Officer at Rockwell Automation, has been appointed to the Company's Board of Directors, effective August 12th, 2024. Gangestad will serve on the Board's Audit Committee. "Nick's deep expertise in finance and financial operations will not only provide additional insights to our Board, but will also give us valuable, first-hand perspectives on
Piyush Mehta, Genpact's Chief Human Resources Officer (CHRO) expands his role to Country Manager, India, reinforcing the company's ongoing commitment to innovation, growth, and talent in the region GURUGRAM, India, April 4, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, announced the expanded role of its CHRO, Piyush Mehta, to Country Manager, India, effective immediately. This move reflects Genpact's unwavering commitment to India and its pivot to an AI-first company. In 2023, Genpact opened
4 - Genpact LTD (0001398659) (Issuer)
4 - Genpact LTD (0001398659) (Issuer)
3 - Genpact LTD (0001398659) (Issuer)
Leveraging Genpact's data, technology and AI expertise to future-proof STADA's finance organization and drive competitive advantages NEW YORK, Sept. 12, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, and STADA (SAZ.DE), a leading manufacturer of consumer healthcare, generic and specialty pharma medicines, today announced the renewal of a multi-year partnership. The new chapter of innovation is aimed at further derisking, scaling, and simplifying STADA's finance operations to drive competitive advantages.
Third time recognition highlights Genpact's ongoing commitment to delivering outsized outcomes for clients NEW YORK, Aug. 27, 2024 /PRNewswire/ -- Genpact (NYSE:G), a global professional services and solutions firm delivering outcomes that shape the future, today announced its inclusion in Forbes' "World's Best Management Consulting Firms" list for 2024. This prestigious recognition, presented by Forbes in collaboration with Statista Inc., is a testament to Genpact's strong industry reputation and expertise in leveraging data, technology, and AI to drive significant value and transformative growth for clients.
NEW YORK, Aug. 22, 2024 /PRNewswire/ -- Genpact (NYSE:G) announced today that its Chief Financial Officer, Mike Weiner, will present at the Citi Global TMT Conference on Wednesday, September 4, 2024, at 3:00 p.m. Eastern Time. The presentation will be webcast live through Genpact's Investor Relations website: www.genpact.com/investors. A replay will be available after the event concludes and will remain accessible until September 5, 2025. About Genpact Genpact (NYSE:G) is a global professional services and solutions firm delivering outcomes that shape the future. Our 125,000+
JP Morgan upgraded Genpact from Underweight to Neutral and set a new price target of $40.00 from $43.00 previously
Mizuho initiated coverage of Genpact with a rating of Neutral and set a new price target of $40.00
Robert W. Baird downgraded Genpact from Outperform to Neutral and set a new price target of $38.00
Despite a market rebalancing away from large tech companies, reflected by an over 10% correction in the Roundhill Magnificent Seven ETF (NASDAQ:MAGS) in the past two weeks, the so-called “Magnificent Seven” companies still comprise an outsized portion of the S&P 500. The Data: The Magnificent 7 comprises seven of the largest U.S. technology companies weighted heavily in the SPDR S&P 500 ETF Trust (NYSE:SPY). Apple Inc (NASDAQ:AAPL), 6.93% of the index. Microsoft Corp (NASDAQ:MSFT), 6.66% of the index. NVIDIA Corp (NASDAQ:NVDA), 5.95% of the index. Alphabet Inc (NASDAQ:G) (NASDAQ:GOOGL), 4.45% of the index. Amazon.com Inc (NASDAQ:AMZN), 3.94% of the index. Meta Platforms
Ratings for Genpact (NYSE:G) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 4 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 0 3 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $37.2, a high estimate of $40.00, and a low estimate of $33.00. This current average has decreased by 3.63% from the previous aver
JP Morgan analyst Tien-Tsin Huang upgrades Genpact (NYSE:G) from Underweight to Neutral and lowers the price target from $43 to $40.
10-Q - Genpact LTD (0001398659) (Filer)
8-K - Genpact LTD (0001398659) (Filer)
8-K - Genpact LTD (0001398659) (Filer)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)
SC 13G/A - Genpact LTD (0001398659) (Subject)